Subscribe To

Price Alert Latest News Economic Calendar News

ITVPF / ITV becomes pharma investor and Reckitt rival via media for equity deal

Weeks after pulling out of investing in the makers of Gogglebox, ITV PLC (LSE:ITV) has today unveiled an investment in a fast growing painkiller. The initial £2 million investment in pain relief brand Flarin is its first consumer healthcare, not surprisingly, and most likely is also the first for any television company. Read More

Demo Live Account See Partner Details

Content Topics

Becomes

Pharma

Investor

Reckitt

Rival

Media

Equity

Deal

Stock

ITVPF

Posted: Aug 15 2023, 10:17

Author Name: Proactive Investors

ITVPF News

By Proactive Investors
August 15, 2023

ITV becomes pharma investor and Reckitt rival via media for equity deal

Weeks after pulling out of investing in the makers of Gogglebox, ITV PLC (LSE:ITV) has today unveiled an investment in a fast growing painkiller. The

By Invezz
July 22, 2022

ITV share price has crashed. Is it a buy ahead of earnings?

ITV (LON: ITV) share price has been in a strong downward trend as investors react to the significant revenue and earnings decline. Shares of the forme

By Proactive Investors
July 13, 2022

BT and ITV investigated over potential pay fixing for sports freelancers

BT Group PLC (LSE:BT.A), ITV PLC (LSE:ITV), Sky and IMG Media are being investigated by the UK competition authorities over whether they are fixing ra

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.